Reprint
Advances in the Management of Cardiovascular Disease
Edited by
September 2023
298 pages
- ISBN978-3-0365-8874-2 (Hardback)
- ISBN978-3-0365-8875-9 (PDF)
This book is a reprint of the Special Issue Advances in the Management of Cardiovascular Disease that was published in
Medicine & Pharmacology
Public Health & Healthcare
Summary
The common threat of cardiovascular diseases (CVDs) constantly holds a dominant position among the leading causes of global mortality. These diseases are everywhere and, combined with many risks, make studying heart problems both challenging and very important. This reprint contains many interesting topics, such as the diagnostic and treatment methods of left main coronary artery (LMCA) disease and the exploration of cardiovascular implications of other diseases. It includes many hot topics related to the cardiovascular disease.
Format
- Hardback
License
© 2022 by the authors; CC BY-NC-ND license
Keywords
class III obesity; cardiac autonomic function; heart rate variability; arrhythmias; insulin resistance; acetylsalicylic acid; ASA; CABG; coronary artery bypass grafting; Alzheimer’s disease; hypertension; osteoporosis; cancer; inflammation; atherosclerosis; catheter ablation; atrial fibrillation; obesity; early recurrence; biomarkers; subsequent percutaneous coronary intervention; no obstructive coronary artery disease; coronary angiography; transcatheter aortic valve implantation; right bundle branch block; left bundle branch block; permanent pacemaker implantation; atrial fibrillation; DOACs; diabetes mellitus; risk index; atrial fibrillation; chronic coronary syndrome; coronary artery disease; mortality; AF-CAD study; predictor; adverse outcome; emergent surgical repair; acute type A dissection; myocardial infarction; ECG; risk stratification; left ventricular systolic dysfunction; primary PCI; heart failure; hemodynamics; congestion; hybrid telerehabilitation; heart failure with reduced ejection fraction; diastolic function; heart failure; treatment strategies; new pharmacological approaches; age-induced changes; sex-related differences; pharmacokinetics; pharmacodynamics; discontinuation of treatment; food supplements; drug interactions; ascending aorta aneurysm; aortic replacement; technique of distal anastomosis; BMI index; professionally active adult population; cardiovascular diseases; obesity; cardiovascular diseases; cigarette smoking; professionally active adult population; cardiologic care; cardiovascular disease; diagnosis; quality of care; treatment; left main coronary artery; percutaneous coronary intervention; coronary artery bypass grafting; coronary artery disease; coronary revascularization; fractional flow reserve; angiography; coronary artery disease; percutaneous coronary intervention; coronary artery bypass graft surgery; pulmonary embolism; follow-up after pulmonary embolism; long term mortality after pulmonary embolism; predictors of survival after pulmonary embolism; screening after pulmonary embolism; chronic thromboembolic pulmonary disease; chronic thromboembolic pulmonary hypertension; diagnostic work-up of post-pulmonary syndrome; n/a